[1] Kermani HR, Hoboubati H, Esmaeili-Mahani S and Asadi-Shekaari M. Induction of intervertebral disc cell apoptosis and degeneration by chronic unpredictable stress. J Neurosurg Spine 2014; 20: 578-584.
[2] Wang J, Chen H, Cao P, Wu X, Zang F, Shi L, Liang L and Yuan W. Inflammatory cytokines induce caveolin-1/β-catenin signalling in rat nucleus pulposus cell apoptosis through the p38 MAPK pathway. Cell Prolif 2016; 49: 362-372.
[3] Han B, Wang HC, Li H, Tao YQ, Liang CZ, Li FC, Chen G and Chen QX. Nucleus pulposus mesenchymal stem cells in acidic conditions mimicking degenerative intervertebral discs give better performance than adipose tissue-derived mesenchymal stem cells. Cells Tissues Organs 2015; 199: 342-352.
[4] Mehrkens A, Matta A, Karim MZ, Kim S, Fehlings MG, Schaeren S and Mark Erwin W. Notochordal cell-derived conditioned medium protects human nucleus pulposus cells from stress-induced apoptosis. Spine J 2017; 17: 579-588.
[5] Koppenaal T, Arensman RM, van Dongen JM, Ostelo R, Veenhof C, Kloek CJJ and Pisters MF. Effectiveness and cost-effectiveness of stratified blended physiotherapy in patients with non-specific low back pain: study protocol of a cluster randomized controlled trial. BMC Musculoskelet Disord 2020; 21: 265.
[6] Hu Y, Huang L, Shen M, Liu Y and Xiong L. Pioglitazone protects compression-mediated apoptosis in nucleus pulposus mesenchymal stem cells by suppressing oxidative stress. Oxid Med Cell Longev 2019; 2019: 1-14.
[7] Karamini A, Bakopoulou A, Andreadis D, Gkiouras K and Kritis A. Therapeutic potential of mesenchymal stromal stem cells in rheumatoid arthritis: a systematic review of in vivo studies. Stem Cell Rev Rep 2020; 16: 276-287.
[8] Sheyn D, Ben-David S, Tawackoli W, Zhou Z, Salehi K, Bez M, De Mel S, Chan V, Roth J, Avalos P, Giaconi JC, Yameen H, Hazanov L, Seliktar D, Li D, Gazit D and Gazit Z. Human iPSCs can be differentiated into notochordal cells that reduce intervertebral disc degeneration in a porcine model. Theranostics 2019; 9: 7506-7524.
[9] Nolta JA, Galipeau J and Phinney DG. Improving mesenchymal stem/stromal cell potency and survival: proceedings from the International Society of Cell Therapy (ISCT) MSC preconference held in May 2018, Palais des Congres de Montreal, Organized by the ISCT MSC Scientific Committee. Cytotherapy 2020; 22: 123-126.
[10] Henry N, Clouet J, Le Bideau J, Le Visage C and Guicheux J. Innovative strategies for intervertebral disc regenerative medicine: From cell therapies to multiscale delivery systems. Biotechnol Adv 2018; 36: 281-294.
[11] Wang W, Deng G, Qiu Y, Huang X, Xi Y, Yu J, Yang X and Ye X. Transplantation of allogenic nucleus pulposus cells attenuates intervertebral disc degeneration by inhibiting apoptosis and increasing migration. Int J Mol Med 2018; 41: 2553-2564.
[12] Qi L, Wang R, Shi Q, Yuan M, Jin M and Li D. Umbilical cord mesenchymal stem cell conditioned medium restored the expression of collagen II and aggrecan in nucleus pulposus mesenchymal stem cells exposed to high glucose. J Bone Miner Metab 2019; 37: 455-466.
[13] Li XC, Tang Y, Wu JH, Yang PS, Wang DL and Ruan DK. Characteristics and potentials of stem cells derived from human degenerated nucleus pulposus: potential for regeneration of the intervertebral disc. BMC Musculoskelet Disord 2017; 18: 242.
[14] Erwin WM, Islam D, Eftekarpour E, Inman RD, Karim MZ and Fehlings MG. Intervertebral disc-derived stem cells: implications for regenerative medicine and neural repair. Spine (Phila Pa 1976) 2013; 38: 211-216.
[15] Lin L, Jia Z, Zhao Y, Wu Y, Zhao X, Li Y, Guo Z, Chen J, Cheng S, Wang D and Ruan D. Use of limiting dilution method for isolation of nucleus pulposus mesenchymal stem/progenitor cells and effects of plating density on biological characteristics and plasticity. Biomed Res Int 2017; 2017: 9765843.
[16] Zhang H, Ma X, Zhang L, Guan X, Bai T and Xue C. The ability to form cartilage of NPMSC and BMSC in SD rats. Int J Clin Exp Med 2015; 8: 4989-4996.
[17] Wang F, Gao ZX, Cai F, Sinkemani A, Xie ZY, Shi R, Wei JN and Wu XT. Formation, function, and exhaustion of notochordal cytoplasmic vacuoles within intervertebral disc: current understanding and speculation. Oncotarget 2017; 8: 57800-57812.
[18] Rodrigues-Pinto R, Berry A, Piper-Hanley K, Hanley N, Richardson SM and Hoyland JA. Spatiotemporal analysis of putative notochordal cell markers reveals CD24 and keratins 8, 18, and 19 as notochord-specific markers during early human intervertebral disc development. J Orthop Res 2016; 34: 1327-1340.
[19] Minogue BM, Richardson SM, Zeef LA, Freemont AJ and Hoyland JA. Transcriptional profiling of bovine intervertebral disc cells: implications for identification of normal and degenerate human intervertebral disc cell phenotypes. Arthritis Res Ther 2010; 12: R22.
[20] Richardson SM, Ludwinski FE, Gnanalingham KK, Atkinson RA, Freemont AJ and Hoyland JA. Notochordal and nucleus pulposus marker expression is maintained by sub-populations of adult human nucleus pulposus cells through aging and degeneration. Sci Rep 2017; 7: 1501.
[21] Wang Z, Leng J, Zhao Y, Yu D, Xu F, Song Q, Qu Z, Zhuang X and Liu Y. N-cadherin maintains the healthy biology of nucleus pulposus cells under high-magnitude compression. Cell Physiol Biochem 2017; 43: 2327-2337.
[22] Thorpe AA, Binch AL, Creemers LB, Sammon C and Le Maitre CL. Nucleus pulposus phenotypic markers to determine stem cell differentiation: fact or fiction? Oncotarget 2016; 7: 2189-2200.
[23] Morimoto T, Kaito T, Matsuo Y, Sugiura T, Kashii M, Makino T, Iwasaki M and Yoshikawa H. The bone morphogenetic protein-2/7 heterodimer is a stronger inducer of bone regeneration than the individual homodimers in a rat spinal fusion model. Spine J 2015; 15: 1379-1390.
[24] Itoh F, Watabe T and Miyazono K. Roles of TGF-beta family signals in the fate determination of pluripotent stem cells. Semin Cell Dev Biol 2014; 32: 98-106.
[25] Yan J, Yang S, Sun H, Guo D, Wu B, Ji F and Zhou D. Effects of releasing recombinant human growth and differentiation factor-5 from poly (lactic-co-glycolic acid) microspheres for repair of the rat degenerated intervertebral disc. J Biomater Appl 2014; 29: 72-80.
[26] Clarke LE, McConnell JC, Sherratt MJ, Derby B, Richardson SM and Hoyland JA. Growth differentiation factor 6 and transforming growth factor-beta differentially mediate mesenchymal stem cell differentiation, composition, and micromechanical properties of nucleus pulposus constructs. Arthritis Res Ther 2014; 16: R67.
[27] Annan H, Rong Xing, Libo Jiang and Zefang Li. Thermosensitive hydrogels loaded with human-induced pluripotent stem cells overexpressing growth differentiation factor-5 ameliorate intervertebral disc degeneration in rats. J Biomed Mater Res 2020; 1: 1-12.
[28] Feng C, Liu H, Yang Y, Huang B and Zhou Y. Growth and differentiation factor-5 contributes to the structural and functional maintenance of the intervertebral disc. Cell Physiol Biochem 2015; 35: 1-16.
[29] Liu W, Zhang Y, Feng X, Li S, Gao Y, Wang K, Song Y, Yang S, Tu J, Shao Z and Yang C. Inhibition of microRNA-34a prevents IL-1beta-induced extracellular matrix degradation in nucleus pulposus by increasing GDF5 expression. Exp Biol Med (Maywood) 2016; 241: 1924-1932.